CYTOKINETICS INC
Company Stats
- Market Cap
- $9.2B
- as of Sep 30, 2026
- Enterprise Value
- $10.0B
- Shares Outstanding
- 139.0M
- Free Float
- 94.7%
Income Statement
- Revenue
- $88.0M
- Operating Income
- -$612.3M
- Net Income
- -$785.0M
- EBITDA
- -$602.1M
- Revenue Growth, 3Y
- -2.4%
- FCF Margin, 3Y Avg
- -2764.3%
- FCF Margin, Worst Year
- -5521.2%
Cash Flow
- Free Cash Flow
- -$534.8M
- FCF Yield
- -5.8%
- Owner FCF Yield
- -7.1%
Balance Sheet
- Cash & Equivalents
- $122.5M
- Total Debt
- $999.0M
- Net Debt
- $876.5M
Returns & Capital
- SBC, 3Y Avg
- $94.1M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $88.0M | -$534.8M | -607.5% |
| FY2024 | $18.5M | -$399.8M | -2164.1% |
| FY2023 | $7.5M | -$415.7M | -5521.2% |
| FY2022 | $94.6M | -$310.9M | -328.6% |
| FY2021 | $70.4M | -$191.4M | -271.8% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 27, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back